COVID-19
Conditions
Brief summary
This study is to clarify the clinical characteristics of severe and critical COVID-19 from March 1st ,2022 to June 9th, 2022 in Shanghai and to explore the relationship between the characteristics and prognosis in these patients.
Detailed description
1. To Describe the clinical characteristics of severe and critical COVID-19. 2. To analyze the relationship between the clinical characteristics and their clinical prognosis; 3. To analyze the relationship between clinical intervention and their clinical prognosis.
Interventions
None listed
Sponsors
Ruijin Hospital
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* severe and critical covid-19 patients who met the Diagnosis and Treatment Plan for new Coronavirus Pneumonia (Ninth Edition) * admission time more than 24 hours
Exclusion criteria
* admission time less than 24 hours
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 28-day mortality | one year | 28-day mortality of severe and critical COVID-19 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| 60-day mortality | one year | 60-day mortality of severe and critical COVID-19 |
| ICU length of stay | one year | ICU length of stay |
| the percentage of organ failure | one year | the percentage of organ failure include respiratory，circulatory failure and so on |
| time for virus to turn negative | one year | time for COVID-19 from positive to negative |
| The overall description | one year | The overall description of the clinical characteristics in severe and critical covid-19 |
Countries
China
Contacts
Primary ContactYing Chen, PhD
Outcome results
None listed